A 16 Week Comparative Study of Fenofibrate Versus Ezetimibe as Add-on Therapy to Atorvastatin
NCT00195793 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 174
Last updated 2007-10-04
Summary
The objective of this study is to evaluate the effects of adding Tricor 145 mg to once daily atorvastatin 20 mg on CHD lipid laboratory parameters.
Conditions
Interventions
- DRUG
-
fenofibrate
- DRUG
-
ezetimibe
- DRUG
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
Global Medical Information · Abbott
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2004-08-31
More Related Trials
-
Atorvastatin Versus Ezetimibe and Fenofibrate as a Lipid-lowering Strategy
NCT00299884 ·Status: COMPLETED
-
Ezetimibe in Patients Hypo-responsive to Statins
NCT00965055 ·Status: TERMINATED ·Phase: PHASE3
-
A Study to Evaluate the Effectiveness of Ezetimibe/Atorvastatin 10 mg/20 mg Combination Tablet Compared to Marketed Ezetimibe 10 mg and Atorvastatin 20 mg Tablets in Participants With High Cholesterol (MK-0653C-185 AM1)
NCT01370590 ·Status: COMPLETED ·Phase: PHASE3
-
Ezetimibe and Atorvastatin vs. Atorvastatin in Patients Age 65 and Older at High Risk for Coronary Heart Disease (CHD)(0653-112)
NCT00418834 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluation of the Efficacy and Safety of Bempedoic Acid (ETC-1002) 180mg, Ezetimibe 10mg, and Atorvastatin 20 mg Triplet Therapy in Patients With Elevated LDL-C
NCT03051100 ·Status: COMPLETED ·Phase: PHASE2
-
Study of Ezetimibe and Fenofibrate in Patients With Mixed Hyperlipidemia (0653-036)(COMPLETED)
NCT00092573 ·Status: COMPLETED ·Phase: PHASE3
-
Assess HDL-C Increase And Non-HDL Lowering Effect Of Torcetrapib/Atorvastatin Vs. Fenofibrate
NCT00139061 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Efficacy Study Comparing ABT-143 to Simvastatin in Subjects With Elevated Levels of Low Density Lipoprotein Cholesterol ("Bad Cholesterol") and Triglycerides
NCT00812955 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Evaluate the Effectiveness of Ezetimibe/Atorvastatin 10 mg/40 mg Combination Tablet Compared to Marketed Ezetimibe 10 mg and Atorvastatin 40 mg Tablets in Participants With High Cholesterol (MK-0653C-190 AM1)
NCT01370603 ·Status: COMPLETED ·Phase: PHASE3
-
Comparison of the Combination of Fenofibrate and Simvastatin Versus Atorvastatin
NCT00362934 ·Status: COMPLETED ·Phase: PHASE3
-
Pharmacological Regulation of Fat Transport in Metabolic Syndrome
NCT00632840 ·Status: COMPLETED ·Phase: PHASE4
-
A Study Comparing The Efficacy & Safety Of Torcetrapib/Atorvastatin And Atorvastatin In Subjects With High Triglycerides
NCT00134498 ·Status: COMPLETED ·Phase: PHASE3
-
Simvastatin and Fenofibrate vs Simvastatin Alone in Patients With Type 2 Diabetes Mellitus and Acute Coronary Syndrome
NCT02015988 ·Status: UNKNOWN ·Phase: PHASE4
-
Comparison of the Combination of Fenofibrate and 40 mg Simvastatin Versus 40 mg Simvastatin Monotherapy
NCT00352183 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of Gemcabene in Hypercholesterolemic Patients as Monotherapy or in Combination With Atorvastatin
NCT02591836 ·Status: COMPLETED ·Phase: PHASE2
-
Study of an Approved Drug With a Statin (a Medication That Lowers Cholesterol Levels) as Compared to Statin Therapy Alone in Patients With High Cholesterol (0653-040)
NCT00092586 ·Status: COMPLETED ·Phase: PHASE3
-
Comparison of the Efficacy and Safety of AtorVastatin mOnotherapy vs. Combination Atorvastatin/Fenofibric Acid
NCT01974297 ·Status: UNKNOWN ·Phase: NA
-
Evaluate Safety and Efficacy of ABT-335 in Combination With Atorvastatin in Subjects With Multiple Abnormal Lipid Levels in the Blood
NCT00300469 ·Status: COMPLETED ·Phase: PHASE3
-
Ezetimibe (SCH 58235) Taken With Either Atorvastatin or Simvastatin in Participants With Familial Hypercholesterolemia (MK-0653-018)
NCT03884452 ·Status: COMPLETED ·Phase: PHASE3
-
Study To Evaluate The Effect Of Torcetrapib/Atorvastatin In Subjects With A Genetic Cholesterol Disorder.
NCT00145431 ·Status: TERMINATED ·Phase: PHASE3
-
Evaluation of ETC-1002, Ezetimibe, and the Combination in Hypercholesterolemic Patients
NCT01941836 ·Status: COMPLETED ·Phase: PHASE2
-
CKD-337(2) Drug-drug Interaction Study
NCT02422030 ·Status: COMPLETED ·Phase: PHASE1
-
Efficacy of Fluvastatin and Fenofibrate in Comparison to Simvastatin and Ezetimibe in Patients With Metabolic Syndrome
NCT00385658 ·Status: COMPLETED ·Phase: PHASE4
-
A Study to Evaluate the Drug-Drug Interaction Between Enlicitide Decanoate (MK-0616) and Atorvastatin in Healthy Adult Participants (MK-0616-024)
NCT06699355 ·Status: COMPLETED ·Phase: PHASE1
-
Efficacy and Safety of the Fixed-dose Combination Atorvastatin/Fenofibrate vs Atorvastatin in Patients With T2D and DLP.
NCT04882293 ·Status: UNKNOWN ·Phase: PHASE3